Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s00261-017-1316-z
Published Online: 2017-09-12
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rayamajhi, Sampanna
Balachandran, Aparna
Katz, Mathew
Reddy, Arun
Rohren, Eric
Bhosale, Priya
Funding for this research was provided by:
NIH/NCI (P30CA016672)
License valid from 2017-09-12